{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:13:38Z","timestamp":1791252818105,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jceh.2014.03.048","type":"journal-article","created":{"date-parts":[[2014,5,24]],"date-time":"2014-05-24T11:15:51Z","timestamp":1400930151000},"page":"S112-S121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"S3","title":["Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"4","author":[{"given":"Shashi B.","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanish","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2014.03.048_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1148\/radiology.154.1.2981112","article-title":"Hepatocellular carcinoma detected by iodized oil","volume":"154","author":"Yumoto","year":"1985","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2014.03.048_bib2","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/0277-5379(83)90028-7","article-title":"Effect of arterial administration of high-moleculan- weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma","volume":"19","author":"Konno","year":"1983","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.jceh.2014.03.048_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1148\/radiology.154.1.2981114","article-title":"Hepatocellular carcinoma detected by iodized oil: use of anticancer agents","volume":"154","author":"Ohishi","year":"1985","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2014.03.048_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1148\/radiology.163.2.3031724","article-title":"Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents","volume":"163","author":"Takayasu","year":"1987","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2014.03.048_bib5","first-page":"125","article-title":"Palliative treatment in advanced hepatocellular carcinoma: has it made any difference?","volume":"30","author":"Paul","year":"2009","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.jceh.2014.03.048_bib6","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1148\/radiol.11081489","article-title":"Transcatheter intraarterial. therapies: rationale and overview","volume":"259","author":"Lewandowski","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2014.03.048_bib7","first-page":"644","article-title":"The hepatic artery","volume":"95","author":"Markowitz","year":"1952","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.jceh.2014.03.048_bib8","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"Llovet","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2014.03.048_bib9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","article-title":"Trans-arterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies","volume":"30","author":"Marelli","year":"2007","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.jceh.2014.03.048_bib10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1148\/radiographics.14.3.8066276","article-title":"Embolotherapy: agents, clinical applications, and techniques","volume":"14","author":"Coldwell","year":"1994","journal-title":"Radiographics"},{"key":"10.1016\/j.jceh.2014.03.048_bib11","first-page":"1236","article-title":"Transcatheter arterial chemoembolization of hepatocellular carcinoma","volume":"45","author":"Chung","year":"1998","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jceh.2014.03.048_bib12","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jvir.2008.02.013","article-title":"Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma","volume":"19","author":"Maluccio","year":"2008","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jceh.2014.03.048_bib13","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2014.03.048_bib14","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep.510270617","article-title":"Trans-arterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution","volume":"27","author":"Bruix","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.03.048_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jceh.2014.03.048_bib16","first-page":"185","article-title":"Improved time to progression for trans-arterial chemoembolization compared with trans-arterial embolization for patients with unresectable hepatocellular carcinoma","volume":"11","author":"Morse","year":"2012","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.jceh.2014.03.048_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1148\/radiology.148.2.6306721","article-title":"Hepatic artery embolization in 120 patients with unresectable hepatoma","volume":"148","author":"Yamada","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2014.03.048_bib18","first-page":"81","article-title":"Hepatic artery embolization in 32 patients with unresectable hepatoma","volume":"26","author":"Yamada","year":"1980","journal-title":"Osaka City Med J"},{"key":"10.1016\/j.jceh.2014.03.048_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.gastro.2006.05.021","article-title":"Prospective cohort study of trans-arterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients","volume":"131","author":"Takayasu","year":"2006","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jceh.2014.03.048_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000327577","article-title":"Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan society of hepatology (JSH) 2010 updated version","volume":"29","author":"Kudo","year":"2011","journal-title":"Dig Dis"},{"issue":"4","key":"10.1016\/j.jceh.2014.03.048_bib21","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association for The Study of The Liver","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.03.048_bib22","first-page":"1","article-title":"Management of hepatocellular carcinoma. An update AASLD practice guidelines","volume":"0","author":"Bruix","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.03.048_bib23","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1053\/j.gastro.2004.09.032","article-title":"Chemoembolization for hepatocellular carcinoma","volume":"127","author":"Bruix","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2014.03.048_bib24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2005.12.015","article-title":"Prospective validation of the barcelona clinic liver Cancer staging system","volume":"44","author":"Cillo","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.03.048_bib25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12072-010-9165-7","article-title":"Asian Pacific Association for the Study of the liver consensus recommendations on hepatocellular carcinoma","volume":"4","author":"Omata","year":"2010","journal-title":"Hepatlogy Int"},{"key":"10.1016\/j.jceh.2014.03.048_bib26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1478-3231.2009.02166.x","article-title":"Systematic review of neoadjuvant trans-arterial chemoembolization for resectable hepatocellular carcinoma","volume":"30","author":"Chua","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2014.03.048_bib27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/jlts.2000.8312","article-title":"Role of trans-arterial chemoembolization before liver resection for hepatocarcinoma","volume":"6","author":"Gerundi","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.03.048_bib28","first-page":"256","article-title":"Influence of preoperative transcatheter arterial chemoembolization on liver function in patients with resectable large hepatocellular carcinoma","volume":"11","author":"Zhou","year":"2003","journal-title":"Gandan Waike Zazhi"},{"issue":"5","key":"10.1016\/j.jceh.2014.03.048_bib29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s00270-007-9111-9","article-title":"Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate","volume":"30","author":"Stockland","year":"2007","journal-title":"Cardiovasc Interv Radiol"},{"issue":"11","key":"10.1016\/j.jceh.2014.03.048_bib30","first-page":"1256","article-title":"A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma","volume":"332","year":"1995","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jceh.2014.03.048_bib31","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of trans-arterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.03.048_bib32","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1440-1746.2008.05728.x","article-title":"Reappraisal of repeated trans-arterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion","volume":"24","author":"Kim","year":"2009","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2014.03.048_bib33","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1245\/s10434-010-1321-8","article-title":"Trans-arterial chemoembolization for unresectable hepatocellular carcinoma with Portal vein tumor thrombosis: a prospective comparative study","volume":"18","author":"Luo","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2014.03.048_bib34","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S0168-8278(12)60009-9","article-title":"Management of HCC","volume":"56","author":"De Lope","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.03.048_bib35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3748\/wjg.v16.i2.264","article-title":"Trans-arterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China","volume":"16","author":"Shi","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2014.03.048_bib36","first-page":"599","article-title":"European Organisation for Research and treatment of Cancer","volume":"48","author":"European Association for Study of Liver","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jceh.2014.03.048_bib37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1097-0142(19920801)70:3<585::AID-CNCR2820700308>3.0.CO;2-#","article-title":"Chemoembolization of hepatocellular carcinomas: a study of the biodistribution and pharmacokinetics of doxorubicin","volume":"70","author":"Raoul","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.jceh.2014.03.048_bib38","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiology.170.3.2536946","article-title":"Transcatheter oily chemoembolization of hepatocellular carcinoma","volume":"170","author":"Nakamura","year":"1989","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2014.03.048_bib39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00280-004-0837-7","article-title":"Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma","volume":"54","author":"Lee","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jceh.2014.03.048_bib40","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/S0959-8049(97)00163-9","article-title":"Epirubicin and etoposide combination chemotherapy to treat hepatocellular carcinoma patients: a phase II study","volume":"33","author":"Bobbio-Pallavicini","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jceh.2014.03.048_bib41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jvir.2012.10.025","article-title":"Single-center comparison of three chemoembolization Regimens for hepatocellular carcinoma","volume":"24","author":"Petruzzi","year":"2013","journal-title":"J Vasc Interv Radiol."},{"key":"10.1016\/j.jceh.2014.03.048_bib42","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1097\/01.RVI.0000182185.47500.7A","article-title":"Safety and efficacy of trans-arterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis","volume":"16","author":"Georgiades","year":"2005","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jceh.2014.03.048_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1478-3231.2008.01916.x","article-title":"Management of advanced hepatocellular carcinoma in the era of targeted therapy","volume":"29","author":"Yau","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2014.03.048_bib44","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1148\/radiology.197.3.7480761","article-title":"Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization","volume":"197","author":"Bartolozzi","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2014.03.048_bib45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/107327480801500110","article-title":"Transcatheter arterial chemoembolization and percutaneous ethanol injection for hepatocellular carcinoma: a retrospective review of the veterans affairs Caribbean healthcare system","volume":"15","author":"Narvaez-Lugo","year":"2008","journal-title":"Cancer Control"},{"key":"10.1016\/j.jceh.2014.03.048_bib46","first-page":"1626","article-title":"Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma","volume":"26","author":"Xu","year":"2006","journal-title":"Nan Fang Yi Ke Da Xue XueBao"},{"key":"10.1016\/j.jceh.2014.03.048_bib47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1148\/radiol.2341031008","article-title":"Large infiltrative hepatocellular carcinomas: treatment with percutaneous intraarterial ethanol injection alone or in combination with conventional percutaneous ethanol injection","volume":"234","author":"Seror","year":"2005","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.jceh.2014.03.048_bib48","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/lt.20418","article-title":"Impact of pretransplantation trans-arterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma","volume":"11","author":"Decaens","year":"2005","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.jceh.2014.03.048_bib49","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1053\/jlts.2003.50106","article-title":"Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome","volume":"9","author":"Graziadei","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jceh.2014.03.048_bib50","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S1051-0443(07)61969-1","article-title":"Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology","volume":"13","author":"Yamakado","year":"2002","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"3","key":"10.1016\/j.jceh.2014.03.048_bib51","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1148\/radiology.219.3.r01ma02669","article-title":"Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization","volume":"219","author":"Pacella","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2014.03.048_bib52","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000156702","article-title":"Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma","volume":"78","author":"Graf","year":"2008","journal-title":"Digestion"},{"issue":"2","key":"10.1016\/j.jceh.2014.03.048_bib53","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00330-006-0343-x","article-title":"Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive trans-arterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT)","volume":"17","author":"Zangos","year":"2007","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jceh.2014.03.048_bib54","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1148\/radiol.2292021329","article-title":"Liver metastases: neoadjuvant downsizing with trans-arterial chemoembolization before laser-induced thermotherapy","volume":"229","author":"Vogl","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2014.03.048_bib55","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1148\/rg.231025055","article-title":"Hepatocellular carcinoma treated with radiofrequency ablation: spectrum of imaging findings","volume":"23","author":"Kim","year":"2003","journal-title":"RadioGraphics"},{"key":"10.1016\/j.jceh.2014.03.048_bib56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11136-006-9133-9","article-title":"Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone","volume":"16","author":"Wang","year":"2007","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jceh.2014.03.048_bib57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/1751-2980.12038","article-title":"Sorafenib in combination with trans-arterial chemoembolization improves survival of unresectable hepatocellular carcinoma: a propensity-score matching study","volume":"14","author":"Bai","year":"2013","journal-title":"J Dig Dis"},{"issue":"4","key":"10.1016\/j.jceh.2014.03.048_bib58","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2214\/AJR.08.1285","article-title":"Identifying feeding arteries during tace of hepatic tumors: comparison of c-arm ct and digital subtraction angiography","volume":"192","author":"Iwazawa","year":"2009","journal-title":"AJR"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2014.03.048_bib59","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1148\/rg.25si055508","article-title":"Recognizing extrahepatic collateral vessels that Supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization","volume":"25","author":"Kim","year":"2005","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.jceh.2014.03.048_bib60","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3348\/kjr.2006.7.4.257","article-title":"Transcatheter arterial chemoembolization of hepatocellular carcinoma: prevalence and causative factors of extrahepatic collateral arteries in 479 patients","volume":"7","author":"Chung","year":"2006","journal-title":"Korean J Radiol"},{"issue":"1","key":"10.1016\/j.jceh.2014.03.048_bib61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1754-9485.2010.02134.x","article-title":"Hepatocellular carcinoma with extrahepatic collateral arterial supply","volume":"54","author":"Cheng","year":"2010","journal-title":"J\u00a0Med Imaging Radiat Oncol"},{"issue":"5","key":"10.1016\/j.jceh.2014.03.048_bib62","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jvir.2007.02.023","article-title":"Hepatocellular carcinoma with internal mammary artery supply: feasibility and efficacy of trans-arterial chemoembolization and factors affecting patient prognosis","volume":"18","author":"Kim","year":"2007","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"8","key":"10.1016\/j.jceh.2014.03.048_bib63","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jvir.2010.04.015","article-title":"Chemoembolization for the treatment of large hepatocellular carcinoma","volume":"21","author":"Miyayama","year":"2010","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jceh.2014.03.048_bib64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1148\/radiology.219.1.r01mr28147","article-title":"Hepatocellular carcinoma: involvement of the internal mammary artery","volume":"219","author":"Nakai","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2014.03.048_bib65","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.jceh.2014.03.048_bib66","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.jceh.2014.03.048_bib67","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver","volume":"35","author":"Bruix","year":"2001","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.jceh.2014.03.048_bib68","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.jceh.2014.03.048_bib69","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1148\/radiol.11110282","article-title":"Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models","volume":"262","author":"Shim","year":"2012","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.jceh.2014.03.048_bib70","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ejca.2012.08.022","article-title":"Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolization","volume":"49","author":"Kim","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jceh.2014.03.048_bib71","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0168-8278(90)90110-D","article-title":"A\u00a0randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma","volume":"11","author":"Pelletier","year":"1990","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.03.048_bib72","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ejso.2004.10.011","article-title":"Outcome of regional and local ablative therapies for hepatocellular carcinoma: a collective review","volume":"31","author":"Jansen","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jceh.2014.03.048_bib73","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<50::AID-CNCR8>3.0.CO;2-I","article-title":"A\u00a0prognostic index of survival of patients with unrestable hepatocellular carcinoma after transcatheter arterial chemoembolization","volume":"88","author":"Liad\u2019o","year":"2000","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.jceh.2014.03.048_bib74","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-2006-927355","article-title":"Single center experience over a 5-year period with sequential transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma","volume":"179","author":"Herber","year":"2007","journal-title":"Rofo"},{"key":"10.1016\/j.jceh.2014.03.048_bib75","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-8278(98)80187-6","article-title":"Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC","volume":"29","author":"Pelletier","year":"1998","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.03.048_bib76","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/0971-3026.82294","article-title":"Trans-arterial chemoembolization (TACE) in patients with unresectable hepatocellular carcinoma: experience from a tertiary care centre in India","volume":"21","author":"Paul","year":"2011","journal-title":"Indian J Radiol. Imaging"},{"issue":"3","key":"10.1016\/j.jceh.2014.03.048_bib77","first-page":"CD004787","article-title":"Trans-arterial (chemo) embolisation for unresectable hepatocellular carcinoma","author":"Oliveri","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jceh.2014.03.048_bib78","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.26000","article-title":"Society of interventional radiology critique and commentary on the Cochrane Report on trans-arterial (chemo)embolisation","volume":"57","author":"Rose","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jceh.2014.03.048_bib79","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1200\/JCO.1984.2.5.498","article-title":"Pharmacologic rationale for regional drug delivery","volume":"2","author":"Collins","year":"1984","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jceh.2014.03.048_bib80","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/j.seminoncol.2010.03.007","article-title":"Trans-arterial chemoembolization, trans-arterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment","volume":"37","author":"Tsochatzis","year":"2010","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jceh.2014.03.048_bib81","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.jhep.2009.09.004","article-title":"Trans-arterial chemotherapy alone versus trans-arterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial","volume":"51","author":"Okusaka","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.03.048_bib82","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1386-6346(01)00174-7","article-title":"Survival and local recurrence rates of hepatocellular carcinoma patients treated by trans-arterial chemolipiodolization with and without embolization","volume":"23","author":"Maeda","year":"2002","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jceh.2014.03.048_bib83","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1051-0443(07)61911-3","article-title":"Determinants of postembolization syndrome after hepatic chemoembolization","volume":"12","author":"Leung","year":"2001","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jceh.2014.03.048_bib84","doi-asserted-by":"crossref","first-page":"906","DOI":"10.2214\/ajr.184.3.01840906","article-title":"Percutaneous femoral catheter placement for long-term chemotherapy infusions: preliminary technical results","volume":"184","author":"Tajima","year":"2005","journal-title":"AJR"},{"key":"10.1016\/j.jceh.2014.03.048_bib85","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1148\/radiology.215.1.r00ap14294","article-title":"Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems","volume":"215","author":"Herrmann","year":"2000","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.jceh.2014.03.048_bib86","doi-asserted-by":"crossref","first-page":"459","DOI":"10.7326\/0003-4819-107-4-459","article-title":"Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma: a randomized trial","volume":"107","author":"Kemeny","year":"1987","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.jceh.2014.03.048_bib87","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archsurg.1990.01410200086013","article-title":"Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial","volume":"125","author":"Martin","year":"1990","journal-title":"Arch Surg"},{"key":"10.1016\/j.jceh.2014.03.048_bib88","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/cncr.10694","article-title":"Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases","volume":"95","author":"Ando","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jceh.2014.03.048_bib89","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1046\/j.1440-1746.1999.01956.x","article-title":"Efficacy of an implanted drug delivery system for advanced hepatocellular carcinoma using 5-fluorouracil, epirubicin and mitomycin C","volume":"14","author":"Seno","year":"1999","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2014.03.048_bib90","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","article-title":"Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics","volume":"46","author":"Varela","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.03.048_bib91","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000329602","article-title":"A\u00a0randomized phase II study of drug-eluting beads versus trans-arterial chemoembolization for unresectable hepatocellular carcinoma","volume":"34","author":"Van Malenstein","year":"2011","journal-title":"Onkologie"},{"key":"10.1016\/j.jceh.2014.03.048_bib92","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.jceh.2014.03.048_bib93","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jvir.2012.11.023","article-title":"Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles","volume":"24","author":"Padia","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jceh.2014.03.048_bib94","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jvir.2012.11.026","article-title":"Safety and efficacy of doxorubicin drug-eluting bead trans-arterial chemoembolization in patients with advanced hepatocellular carcinoma","volume":"24","author":"Prajapati","year":"2013","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.jceh.2014.03.048_bib95","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.diii.2012.05.001","article-title":"Result and cost of hepatic chemoembolization with drug eluting beads in 21 patients","volume":"94","author":"Vadot","year":"2013","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.jceh.2014.03.048_bib96","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.24451","article-title":"Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation","volume":"54","author":"Sangro","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.03.048_bib97","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.ijrobp.2004.09.004","article-title":"Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers","volume":"60","author":"Kennedy","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jceh.2014.03.048_bib98","first-page":"1209","article-title":"Dosimetric techniques in 90Y-microsphere therapy of liver cancer: the MIRD equations for dose calculations","volume":"47","author":"Gulec","year":"2006","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jceh.2014.03.048_bib99","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1007\/s00259-010-1566-2","article-title":"99mTc-labelled macroaggregated albumin (MAA) scintigraphy for planning treatment with 90Y microspheres","volume":"37","author":"Lambert","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jceh.2014.03.048_bib100","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.2967\/jnumed.110.075861","article-title":"Efficacy and toxicity related to treatment of hepatocellular carcinoma with 90Y-SIR spheres: radiobiologic considerations","volume":"51","author":"Strigari","year":"2010","journal-title":"J\u00a0Nucl Med"},{"issue":"1","key":"10.1016\/j.jceh.2014.03.048_bib101","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hep.21980","article-title":"Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis","volume":"47","author":"Kulik","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.03.048_bib102","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jvir.2010.04.012","article-title":"Radioembolization with use of Yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis","volume":"21","author":"Inarrairaegui","year":"2010","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"5","key":"10.1016\/j.jceh.2014.03.048_bib103","first-page":"1156","article-title":"Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma","volume":"26","author":"Raoul","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.03.048_bib104","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1053\/j.gastro.2004.09.034","article-title":"Yttrium-90 microspheres for the treatment of hepatocellular carcinoma","volume":"127","author":"Geschwind","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2014.03.048_bib105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2014.03.048_bib106","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1148\/radiol.2432051246","article-title":"Inoperable hepatocellular carcinoma; trans-arterial rhenium-188 HDD-labelled iodised oil for treatment-prospective multicentre clinical TRIAL","volume":"243","author":"Kumar","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2014.03.048_bib107","doi-asserted-by":"crossref","first-page":"s40","DOI":"10.1053\/j.semnuclmed.2007.10.006","article-title":"International Atomic Energy Agency sponsored multination study of intra-arterial Rhenium 188 labeled lipiodol in the treatment of inoperable hepatocellular carcinoma: results with special emphasis on prognostic value dosimetric study","volume":"38","author":"Bernal","year":"2008","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.jceh.2014.03.048_bib108","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00042737-200602000-00016","article-title":"Management of multiple intrahepatic recurrences after radiofrequency ablation of hepatocellular carcinoma with rhenium-188-HDD-lipiodol","volume":"18","author":"Kumar","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.jceh.2014.03.048_bib109","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A\u00a0comparative analysis of trans-arterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jceh.2014.03.048_bib110","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/cncr.24884","article-title":"Therapeutic equivalence in survival for hepatic arterial chemoembolization and Yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study","volume":"116","author":"Carr","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jceh.2014.03.048_bib111","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jvir.2009.10.013","article-title":"Comparison of Yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma","volume":"21","author":"Kooby","year":"2010","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jceh.2014.03.048_bib112","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.10.049","article-title":"Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma","volume":"140","author":"Salem","year":"2011","journal-title":"Gastroenterology"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688314002254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688314002254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:01:49Z","timestamp":1760853709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688314002254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":112,"alternative-id":["S0973688314002254"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2014.03.048","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2014.03.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 INASL. Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}